MedPath

Bile Reflux Gastropathy after Therapeutic Biliary Interventions

Phase 3
Completed
Conditions
Digestive System
Registration Number
PACTR202111578379735
Lead Sponsor
Zagazig University Hospitals
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
288
Inclusion Criteria

1-refractory epigastric pain and dyspeptic symptoms after therapeutic biliary interventions with
2- history of poor response to prokinetics, mucosa-protective medicines, H2-blockers and/or proton-pump inhibitors (PPI).

Exclusion Criteria

1- unstable cardiopulmonary, neurologic, or cardiovascular status,
2- other causes of biliary diseases (CBD strictures, and hepatolithiasis),
3- structural abnormalities of the esophagus, stomach, or small intestine,
4- patients who underwent bariatric surgery out of the scope of the study,
5- patients on long-term non-steroidal analgesics, and
6- patients on oral contraceptive drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.